The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

The Effective Statistician - in association with PSI

Will AI Replace Statisticians? The Future of Statistics in Pharma

Download it: MP3 | AAC | OGG | OPUS
Read transcript

Why you should listen

Listen to this episode to:

  • Understand how AI may change statistical work in the pharmaceutical industry
  • Recognize the limitations of using AI in clinical trial design and decision-making
  • Explore why human judgment, collaboration, and accountability still matter
  • Learn which capabilities statisticians should strengthen for an AI-enabled future
  • Discover practical ways to experiment with AI in your daily work
  • Approach the future of statistics with greater confidence and curiosity

Episode highlights with timestamps

  • 01:30 – Will AI make statisticians redundant?
    I introduce the central question behind my conversation with Chris.
  • 03:27 – Can AI create an entire clinical study package?
    We examine what AI can generate—and why plausible outputs still require careful scrutiny.
  • 05:16 – A protocol is more than a document
    Chris explains how document development supports alignment, precision, and better scientific discussions.
  • 07:08 – Navigating real-world trade-offsWe discuss the challenge of balancing timelines, budgets, sample sizes, biomarkers, and broader development goals.
  • 10:18 – Combining human and artificial intelligence
    We consider how AI can complement experience rather than simply compete with it.
  • 12:41 – Why keeping a human in the loop matters
    Chris highlights an important challenge surrounding review quality and confidence in AI-generated work.
  • 13:37 – Building trust in an AI-enabled workplace
    We explore what statisticians provide beyond technical competence.
  • 15:53 – Who remains accountable when AI gets it wrong?
    Our conversation turns to responsibility, risk, and the limits of delegating decisions to technology.
  • 17:17 – How statisticians can prepare for the future
    Chris offers practical guidance for professionals working with clinical trials, real-world evidence, and other data projects.
  • 22:07 – A promising future for statisticians
    We close by considering how AI could create new opportunities for the profession.

Links and Resources:

🔗 Read Chris Harbron’s paper: Will the Pharmaceutical Industry Need Statisticians in an AI World?

🔗 Learn more about Chris Harbron and PoshStatsConnect with Chris Harbron on LinkedIn

🔗 Learn more about PSI and become a member

🔗 The Effective Statistician Academy – I offer free and premium resources to help you become a more effective statistician.

🔗 My New Book: How to Be an Effective Statistician - Volume 1 – It’s packed with insights to help statisticians, data scientists, and quantitative professionals excel as leaders, collaborators, and change-makers in healthcare and medicine.

Join the Conversation:
Did you find this episode helpful? Share it with your colleagues and let me know your thoughts! Connect with me on LinkedIn and be part of the discussion.

Subscribe & Stay Updated:
Never miss an episode! Subscribe to The Effective Statistician on your favorite podcast platform and continue growing your influence as a statistician.


Comments


New comment

Your name or nickname, will be shown publicly
At least 10 characters long
By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.

About this podcast

The podcast from statisticians for statisticians to have a bigger impact at work. This podcast is set up in association with PSI - Promoting Statistical Insight. This podcast helps you to grow your leadership skills, learn about ongoing discussions in the scientific community, build you knowledge about the health sector and be more efficient at work. This podcast helps statisticians at all levels with and without management experience. It is targeted towards the health, but lots of topics will be important for the wider data scientists community.

by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry

Subscribe

Follow us